Efficacy and Tolerability of Osimertinib and Sotorasib Combination Treatment for Osimertinib Resistance Caused by KRAS G12C Mutation: A Report of Two Cases.
- Resource Type
- Article
- Authors
- Ernst, Sophie M.; Uzun, Sevim; Paats, Marthe S.; van Marion, Ronald; Atmodimedjo, Peggy N.; de Jonge, Evert; van Schaik, Ron H.N.; Aerts, Joachim G.J.V.; von der Thüsen, Jan H.; Dubbink, Hendrikus J.; Dingemans, Anne-Marie C.
- Source
- JCO Precision Oncology. 12/14/2023, Vol. 7, p1-5. 5p.
- Subject
- *OSIMERTINIB
*RAS oncogenes
- Language
- ISSN
- 2473-4284
Two cases show osimertinib/sotorasib combination could be effective in KRAS G12C-driven osimertinib resistance. [ABSTRACT FROM AUTHOR]